BCRX · ISSUER CIK 882796
BIOCRYST PHARMACEUTICALS INC
Between Aug 1, 2026 and Oct 29, 2026, 5 BIOCRYST PHARMACEUTICALS INC insiders reported $0.00 of open-market purchases and $0.00 of sales on SEC Form 4.
↗5 insiders filed
Original Form 4 filings from Aug 1, 2026 to Oct 29, 2026. No open-market sales in the window.
$0.00Insider buying
$0.00Insider selling
$0.00Net open-market
Sep 2, 2026Latest filing
| Ticker | Insider | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 2, 202616:16 | Aug 31, 2026 | BCRX | Director | A · Grant | $9.70 | +644 | 1,340,419 | +0% | $6K | ||
| Sep 2, 202616:13 | Aug 31, 2026 | BCRX | Director | A · Grant | $9.70 | +1,288 | 33,226 | +4% | $12K | ||
| Sep 2, 202616:10 | Aug 31, 2026 | BCRX | Director | A · Grant | $9.70 | +1,159 | 109,642 | +1% | $11K | ||
| Sep 2, 202616:06 | Aug 31, 2026 | BCRX | Director | A · Grant | $9.70 | +644 | 47,821 | +1% | $6K | ||
| Sep 2, 202616:04 | Aug 31, 2026 | BCRX | Director | A · Grant | $9.70 | +1,288 | 36,747 | +4% | $12K |